“Modified capsule shaped, dull red, film-coated tablets debossed with E-18 on one side and plain on the other side containing moxifloxacin hydrochloride (equivalent to 400 mg moxifloxacin)”
E 18 pill
Pill with imprint E 18 is red, capsule, 17 mm and has been identified as Moxifloxacin Hydrochloride 400 mg. It is used for bronchitis, sinus infections and urinary tract infections (UTIs). It is supplied by Redpharm Drug, Inc.
Moxifloxacin Hydrochloride 400 mg
- Imprint
- E 18
- Strength
- 400 mg
- Used for
- Bronchitis, sinus infections and urinary tract infections (UTIs)
- Color
- Red
- Shape
- Capsule / oblong
- Size
- 17 mm
- Score
- No score line
- Form
- Tablet, film coated
- Manufacturer
- Redpharm Drug, Inc
- Drug class
- Antibiotic (fluoroquinolone)
- NDC
- 67296-1616, 57237-156, 67296-1616-5, 50268-576, 65862-603, 50268-576-11, 50268-576-13, 50090-6609, 50090-6609-0, 50090-6609-1, 50090-7244, 50090-7244-1, 57237-156-30, 65862-603-30, 65862-603-99, 65862-603-10, 65862-603-55, 50090-7665, 50090-7665-0, 0904-7407, 0904-7407-04, 0904-7407-06, 71335-2329, 71335-2329-1, 71335-2329-2, 71335-2815, 71335-2815-1, 71335-2815-2, 72789-038, 72789-038-10, 72789-037, 72789-037-10, 72789-350, 72789-350-10, 70518-3738, 70518-3738-0, 68084-722, 68084-722-11, 68084-722-65, 70518-4458
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Moxifloxacin used for?
Moxifloxacin is used for bronchitis, sinus infections, urinary tract infections (UTIs) and pneumonia.
- Medicine type
- Antibiotic (fluoroquinolone)
Official uses from the US prescribing label
Community Acquired Pneumonia
Moxifloxacin tablets are indicated in adult patients for the treatment of Community Acquired Pneumonia caused by susceptible isolates of Streptococcus pneumoniae(including multi-drug resistant Streptococcus pneumoniae[MDRSP]), Haemophilus influenzae, Moraxella catarrhalis,methicillin-susceptible Staphylococcus aureus, Klebsiella pneumoniae, Mycoplasma pneumoniae,or Chlamydophila pneumoniae.
MDRSP isolates are isolates resistant to two or more of the following antibacterial drugs: penicillin (minimum inhibitory concentrations [MIC] ≥ 2 mcg/mL), 2nd generation cephalosporins (for example, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole.
Uncomplicated Skin and Skin Structure Infections
Moxifloxacin tablets are indicated in adult patients for the treatment of Uncomplicated Skin and Skin Structure Infections caused by susceptible isolates of methicillin-susceptible Staphylococcus aureusor Streptococcus pyogenes.
Complicated Skin and Skin Structure Infections
Moxifloxacin tablets are indicated in adult patients for the treatment of Complicated Skin and Skin Structure Infections caused by susceptible isolates of methicillin-susceptible Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae,or Enterobacter cloacae.
Complicated Intra-Abdominal Infections
Moxifloxacin tablets are indicated in adult patients for the treatment of Complicated Intra-Abdominal Infections (cIAI) including polymicrobial infections such as abscess caused by susceptible isolates of Escherichia coli, Bacteroides fragilis, Streptococcus anginosus, Streptococcus constellatus, Enterococcus faecalis, Proteus mirabilis, Clostridium perfringens, Bacteroides thetaiotaomicron,or Peptostreptococcusspecies.
Plague
Moxifloxacin tablets are indicated in adult patients for the treatment of plague, including pneumonic and septicemic plague, due to susceptible isolates of Yersinia pestisand prophylaxis of plague in adult patients. Efficacy studies of moxifloxacin could not be conducted in humans with plague for feasibility reasons. Therefore, this indication is based on an efficacy study conducted in animals only.
Acute Bacterial Sinusitis
Moxifloxacin tablets are indicated in adult patients for the treatment of acute bacterial sinusitis (ABS) caused by susceptible isolates of Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis.
Because fluoroquinolones, including moxifloxacin tablets, have been associated with serious adverse reactions and for some patients ABS is self-limiting, reserve moxifloxacin tablets for treatment of ABS in patients who have no alternative treatment options.
Acute Bacterial Exacerbation of Chronic Bronchitis
Moxifloxacin tablets are indicated in adult patients for the treatment of Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB) caused by susceptible isolates of Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae,methicillin-susceptible Staphylococcus aureus,or Moraxella catarrhalis.
Because fluoroquinolones, including moxifloxacin tablets, have been associated with serious adverse reactions and for some patients ABECB is self-limiting, reserve moxifloxacin tablets for treatment of ABECB in patients who have no alternative treatment options.
Usage
To reduce the development of drug-resistant bacteria and maintain the effectiveness of moxifloxacin tablets and other antibacterial drugs, moxifloxacin tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
From the FDA-approved label on DailyMed (published Sep 14, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- One side shows E-18 and the other side is plain.
- It is red, capsule, 17 mm.
- The score line, coating and any logo match the photo.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Moxifloxacin Hydrochloride
Inactive: Magnesium Stearate, Polyethylene Glycol 4000, Hypromellose 2910 (6 Mpa.s), Povidone K30, Sodium Starch Glycolate Type A Potato, Titanium Dioxide, Ferric Oxide Red, Microcrystalline Cellulose
Also distributed by
Avpak, A-S Medication Solutions, Rising Pharma Holdings, Inc., Aurobindo Pharma Limited, Major Pharmaceuticals, Bryant Ranch Prepack, Pd-Rx Pharmaceuticals, Inc., Remedyrepack Inc., American Health Packaging
Other pills with imprint E 18
Same imprint, different listing. Check the color, size and maker against your pill.
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
Amneal 1502
Phenoxybenzamine Hydrochloride 10 mg
Red, capsule, 16 mm
Used for severe high blood pressure and bladder leaks
-
LU E01
Rifampin 150 mg
Red, capsule, 18 mm
Used for tuberculosis (TB) and brucellosis
-
AA1
Methyltestosterone 10 mg
Red, capsule, 18 mm
Used for low testosterone and erectile dysfunction (ED)
Schedule III
-
A226
Amantadine 100 mg
Red, capsule, 18 mm
Used for Parkinson's disease and flu
-
LA 44
Pregabalin 100 mg
Red, capsule, 16 mm
Used for seizures and nerve pain after shingles
Schedule V
-
barr 302 50
Hydroxyzine Pamoate 50 mg
Red & yellow, capsule, 16 mm
Used for anxiety and withdrawal symptoms
Other Moxifloxacin pills
- BAYER M400 Moxifloxacin Hydrochloride 400 mg Red, oval, 17 mm Used for bronchitis and sinus infections
- n 034 Moxifloxacin Hydrochloride 400 mg Pink, capsule, 17 mm Used for bronchitis and sinus infections
- 112 Moxifloxacin 400 mg Orange, capsule, 19 mm Used for bronchitis and sinus infections
- 103 J Moxifloxacin 400 mg Pink, capsule, 18 mm Used for bronchitis and sinus infections
- S9 Moxifloxacin Hydrochloride 400 mg White, capsule, 19 mm Used for bronchitis and sinus infections
- T75 Moxifloxacin 400 mg Pink, capsule, 17 mm Used for bronchitis and sinus infections
- CE 312 Moxifloxacin 400 mg Pink, capsule, 17 mm Used for bronchitis and sinus infections
- 93 7387 Moxifloxacin Hydrochloride 400 mg Pink, oval Used for bronchitis and sinus infections